Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars
NCT06257355
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Corneal Scar
Interventions
BIOLOGICAL:
CSB-001 Ophthalmic Solution 0.1%
Sponsor
Claris Biotherapeutics, Inc.